tiprankstipranks
Trending News
More News >
Opko Health (OPK)
:OPK
US Market
Advertisement

Opko Health (OPK) Technical Analysis

Compare
3,298 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Opko Health’s (OPK) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Opko Health is a Sell.
Opko Health’s (OPK) 20-Day exponential moving average is 1.44, while Opko Health’s (OPK) share price is $1.55, making it a Buy.
Opko Health’s (OPK) 50-Day exponential moving average is 1.40, while Opko Health’s (OPK) share price is $1.55, making it a Buy.

Opko Health (OPK) Pivot Points

Oct 02, 2025, 12:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.38
1.41
1.44
1.47
1.50
1.53
1.56
Fibonacci
1.41
1.43
1.45
1.47
1.49
1.51
1.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Opko Health (OPK) Moving Averages

Oct 02, 2025, 12:57 AM
Period
Simple
Exponential
MA5
1.48Buy
1.49Buy
MA10
1.46Buy
1.46Buy
MA20
1.43Buy
1.44Buy
MA50
1.38Buy
1.40Buy
MA100
1.35Buy
1.40Buy
MA200
1.47Buy
1.46Buy
Opko Health’s (OPK) 10-Day exponential moving average is 1.46, while Opko Health’s (OPK) share price is $1.55, making it a Buy.
Opko Health’s (OPK) 100-Day exponential moving average is 1.40, while Opko Health’s (OPK) share price is $1.55, making it a Buy.
Opko Health’s (OPK) stock price is $1.55 and Opko Health’s (OPK) 50-day simple moving average is 1.38, creating a Buy signal.
Opko Health’s (OPK) stock price is $1.55 and Opko Health’s (OPK) 100-day simple moving average is 1.35, creating a Buy signal.
Opko Health’s (OPK) stock price is $1.55 and Opko Health’s (OPK) 200-day simple moving average is 1.47, creating a Buy signal.

Opko Health (OPK) Technical Indicators

Oct 02, 2025, 12:57 AM
Name
Value
Implied Action
RSI (14)
65.28
Neutral
STOCH (9,6)
71.73
Neutral
STOCHRSI (14)
72.04
Neutral
MACD (12,26)
0.03
Sell
ADX (14)
17.92
Buy
Williams %R
0.00
Buy
CCI (14)
189.59
Sell
ATR (14)
0.06
-
Ultimate Oscillator
59.48
Neutral
ROC
9.93
Buy
Opko Health’s (OPK) Relative Strength Index (RSI) is 65.28, creating a Neutral signal.
Opko Health’s (OPK) Trend Strength Indicator (ADX) is 17.92, creating a Buy signal.
Opko Health’s (OPK) Commodity Channel Index (CCI) is 189.59, creating a Sell signal.
Opko Health’s (OPK) Price Rate of Change (ROC) is 9.93, creating a Buy signal.

FAQ

Is OPK a Buy, Hold, or Sell?
Based on OPK’s technical indicators, OPK is a Strong Buy.
    What is OPK’s RSI (14)?
    OPK’s RSI (14) is 65.28, which suggests OPK is a Neutral.
      What is OPK’s MACD?
      OPK’s MACD is 0.03, which suggests OPK is a Sell.
        What is OPK’s 5-day moving average?
        OPK’s 5-day moving average is 1.48, which suggests OPK is a Buy.
          What is OPK’s 20-day moving average?
          OPK 20-day moving average is 1.43, which suggests OPK is a Buy.
            What is OPK’s 50-day moving average?
            OPK’s 50-day moving average is 1.38, which suggests OPK is a Buy.
              What is OPK’s 200-day moving average?
              OPK’s 200-day moving average is 1.47, which suggests OPK is a Buy.
                What is OPK’s Williams % R (14)?
                OPK’s Williams % R (14) is 0.00, which suggests OPK is a Buy.
                  What is OPK’s CCI (14)?
                  OPK’s CCI (14) is 189.59, which suggests OPK is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis